Lipitor's specter casts earnings shadow, diabetes boosts Novo
November 01 2012
Lipitor patent loss continued to sting Pfizer in third quarter earnings, but the company's Zoetis spin-off remains on track. Elsewhere ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.